332 related articles for article (PubMed ID: 25543982)
1. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy.
Ma X; Gong A; Chen B; Zheng J; Chen T; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2015 Feb; 126():44-9. PubMed ID: 25543982
[TBL] [Abstract][Full Text] [Related]
2. Functionalization of Magnetic Nanoparticles by Folate as Potential MRI Contrast Agent for Breast Cancer Diagnostics.
Heydari Sheikh Hossein H; Jabbari I; Zarepour A; Zarrabi A; Ashrafizadeh M; Taherian A; Makvandi P
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899812
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
4. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.
Kumar M; Singh G; Arora V; Mewar S; Sharma U; Jagannathan NR; Sapra S; Dinda AK; Kharbanda S; Singh H
Int J Nanomedicine; 2012; 7():3503-16. PubMed ID: 22848174
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
7. A pH-sensitive polymer based precise tumor targeting strategy with reduced uptake of nanoparticles by non-cancerous cells.
Li Z; Ma X; Xia Y; Qian K; Akakuru OU; Luo L; Zheng J; Cui P; Shen Z; Wu A
J Mater Chem B; 2019 Oct; 7(39):5983-5991. PubMed ID: 31532444
[TBL] [Abstract][Full Text] [Related]
8. Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity.
Hong GB; Zhou JX; Yuan RX
Int J Nanomedicine; 2012; 7():2863-72. PubMed ID: 22745549
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
10. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K
Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995
[TBL] [Abstract][Full Text] [Related]
11. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging.
Li L; Gao F; Jiang W; Wu X; Cai Y; Tang J; Gao X; Gao F
Drug Deliv; 2016 Jun; 23(5):1726-33. PubMed ID: 25715808
[TBL] [Abstract][Full Text] [Related]
13. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
14. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
[TBL] [Abstract][Full Text] [Related]
16. Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance.
Dadfar SM; Camozzi D; Darguzyte M; Roemhild K; Varvarà P; Metselaar J; Banala S; Straub M; Güvener N; Engelmann U; Slabu I; Buhl M; van Leusen J; Kögerler P; Hermanns-Sachweh B; Schulz V; Kiessling F; Lammers T
J Nanobiotechnology; 2020 Jan; 18(1):22. PubMed ID: 31992302
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble superparamagnetic magnetite nanoparticles with biocompatible coating for enhanced magnetic resonance imaging.
Xiao L; Li J; Brougham DF; Fox EK; Feliu N; Bushmelev A; Schmidt A; Mertens N; Kiessling F; Valldor M; Fadeel B; Mathur S
ACS Nano; 2011 Aug; 5(8):6315-24. PubMed ID: 21790153
[TBL] [Abstract][Full Text] [Related]
18. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells.
Wang X; Tu M; Tian B; Yi Y; Wei Z; Wei F
Anal Biochem; 2016 Nov; 512():8-17. PubMed ID: 27523645
[TBL] [Abstract][Full Text] [Related]
20. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
